Lav.Bb

LAV.BB maintains a strong liquidity position, with a current ratio of 5.0, indicating the company can easily cover its short-term liabilities with its current assets. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its cash and equivalents of 914,000 BGN and a negative net cash position after subtracting total debt. The company's return on equity of 7.38% and return on assets of 6.37% are below the industry median for the Personal Products sector, suggesting that LAV.BB is underperforming in terms of capital efficiency and asset utilization.

The company's profitability is modest, with a net income of 2,191,000 BGN and an operating income of 2,296,000 BGN. Gross profit of 10,852,000 BGN represents 41.7% of total revenue, which is in line with the industry average. However, the company's operating margin of 8.8% is below the median for the sector, indicating that LAV.BB is not as efficient in converting revenue into operating profit as its peers.

LAV.BB's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if demand in its primary market declines. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.07, indicating that it is primarily financed through equity rather than debt.

Looking ahead, LAV.BB is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected for the next fiscal year. The company's capital expenditure of -787,000 BGN suggests that it is not investing heavily in new projects or infrastructure, which may limit its long-term growth potential. The company's risk assessment indicates a low dilution risk, with no near-term pressure to issue additional shares.

Recent filings and transcripts do not indicate any material events or strategic shifts for LAV.BB. The company has not disclosed any significant new product launches, market expansions, or regulatory challenges that would impact its financial performance in the near term.